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Abstract
The oviduct is an exquisitely designed organ that functions in picking-up ovulated oocytes,
transporting gametes in opposite directions to the site of fertilization, providing a suitable
environment for fertilization and early development, and transporting preimplantation embryos to
the uterus. A variety of biological processes can be studied in oviducts making them an excellent
model for toxicological studies. This review considers the role of the oviduct in oocyte pick-up and
embryo transport and the evidence that chemicals in both mainstream and sidestream cigarette
smoke impair these oviductal functions. Epidemiological data have repeatedly shown that women
who smoke are at increased risk for a variety of reproductive problems, including ectopic
pregnancy, delay to conception, and infertility. In vivo and in vitro studies indicate the oviduct is
targeted by smoke components in a manner that could explain some of the epidemiological data.
Comparisons between the toxicity of smoke from different types of cigarettes, including harm
reduction cigarettes, are discussed, and the chemicals in smoke that impair oviductal functioning
are reviewed.
A. Background
Exposure to cigarette smoke may be either active or pas-
sive, and the type of smoke inhaled in each case has a dif-
ferent origin. Mainstream smoke is the smoke that an
active smoker inhales with each puff, while sidestream
smoke, the main component of environmental tobacco
smoke, burns off the end of a lit cigarette and is the smoke
inhaled by passive smokers. While the association
between inhalation of mainstream smoke and cardiovas-
cular disease and cancer has been established for many
years, the impact of smoking on reproduction is recog-
nized, but less well characterized and less well known [1].
Epidemiological studies have repeatedly shown that
women of child bearing age who actively inhale main-
stream smoke have higher rates of infertility, spontaneous
abortion, ectopic pregnancy, tubal infertility, increased
time to conception, and intrauterine growth retardation
than nonsmokers [2-15]. Increases in infertility and
ectopic pregnancy in smokers could be due to impairment
of oviductal functioning. In patients with primary tubal
infertility, 39% were smokers when they started trying to
conceive in contrast to only 16% in the non-smoking
group (OR = 2.7) [10]. Heavy smoking (> 5 pack-years)
increased the odds ratio to 4.2, and similar dose related
effects have been repeatedly observed [11,16].
The realization that sidestream smoke exposure adversely
affects human health is even more recent [17]. In 1992,
the Environmental Protection Agency published a mono-
graph summarizing evidence that exposure to
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environmental tobacco smoke can produce adverse effects
on cardiovascular and lung health and encouraged
broader investigation in this area [17]. Subsequently, a
number of studies have addressed the effect of passive
smoking on various aspects of human health including
reproduction and have concluded that adverse reproduc-
tive outcomes, such as delayed time to conception and
reduced birth weight, do occur as a consequence of expo-
sure to environmental tobacco smoke during pregnancy
[18-30]. Moreover, an in vitro fertilization lab recently
concluded that while fertilization rates and embryo qual-
ity were similar in smokers and non-smokers, implanta-
tion and pregnancy rates were adversely affected by both
active and passive smoking when compared to non-smok-
ing controls [31].
Recent reviews have addressed issues of cigarette smoke
exposure and various facets of reproduction including
delayed time to conception, ovarian effects and premature
menopause, implantation failure, fetal growth restriction
and growth retardation, placental abnormalities, reduced
fecundity, congenital abnormalities, and effects on male
reproduction [32-34]. However, most prior reviews have
not considered smoke's interaction with the oviduct, an
organ vital to reproduction. The purpose of this paper is
to review the functions of the oviduct, in particular those
that involve movement of gametes and embryos, and to
evaluate evidence that exposure to mainstream or side-
stream cigarette smoke can negatively impact oviductal
functioning and thereby adversely affect reproductive out-
comes. We will also consider evidence that commercial
cigarettes, including harm reduction and light cigarettes,
contain toxicants that impair oviductal functioning, and
we will discuss the specific chemicals in smoke that impair
oviductal functioning. Some of these chemicals adversely
affect oviductal processes at extremely low doses, are often
considered safe, and are added to cigarettes and other con-
sumer items.
B. Functions of the oviduct
The oviduct, which is divided anatomically into the
infundibulum, ampulla, and isthmus, plays important
roles in mammalian reproduction (Fig. 1) [35-41]. The
infundibulum is responsible for picking-up the oocyte
cumulus complex following ovulation and moving it into
the ampulla where fertilization occurs. Simultaneously,
the oviduct moves sperm in the opposite direction from a
reservoir near the uterotubal junction toward the ampulla
[42]. The oviduct also provides a suitable microenviron-
ment for capacitation of spermatozoa, fertilization, pre-
implantation development, and transport of the
preimplantation embryos to the uterus. The movement of
the embryo through the oviduct to the uterus is carefully
timed by ovarian hormones and signals from the embryos
[43]. While smoke exposure could affect any of these
processes, most current evidence links smoke to effects on
oocyte cumulus complex pick-up and embryo transport,
which will be reviewed in more detail in the following
sections.
(1) Oocyte cumulus complex pick-up by the infundibulum
The infundibulum is the portion of the oviduct closest to
the ovary and is responsible for picking up the oocyte
cumulus complex following its ovulation from a mature
ovarian follicle [44,45]. The oocyte cumulus complex
consists of a centrally located oocyte, which is in turn sur-
rounded by the zona pellucida, corona radiata, and cumu-
lus cells (Fig. 2) [46-48]. The complex contains 5,000–
8,000 cumulus cells, depending on the species, and these
are separated from each other by an extracellular matrix,
which plays an important role in the pick-up process. The
structure and distribution of the extracellular matrix
between cumulus cells has been well characterized in a
number of species including humans [46,49-52]. Bio-
chemically, the matrix is rich in hyaluronan (hyaluronic
acid) [53-55], which is cross-linked by inter-alpha trypsin
Schematic diagram showing the three anatomical regions of  the oviduct (infundibulum, ampulla, and isthmus) and the  regions of the oviduct where oocyte cumulus complexes and  preimplantation embryos can be found Figure 1
Schematic diagram showing the three anatomical regions of 
the oviduct (infundibulum, ampulla, and isthmus) and the 
regions of the oviduct where oocyte cumulus complexes and 
preimplantation embryos can be found. Oocyte cumulus 
complexes are ovulated from ovaries (#1), picked-up by the 
outer surface of the infundibulum (#2), and moved toward 
the ostium (unlabeled arrow) by ciliary beating then into the 
ampulla for fertilization (#3). Fertilized eggs and embryos are 
transported through the isthmus to the uterine cavity where 
they then can implant in the uterine wall.Reproductive Biology and Endocrinology 2005, 3:52 http://www.rbej.com/content/3/1/52
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inhibitor [56-58]. TSG-6 (the secreted product of the
tumor necrosis factor-stimulated gene 6) also binds to
hyaluronan in the cumulus matrix [59-61]. The impor-
tance of these matrix components to reproduction is dem-
onstrated by the TSG-6 knockout mouse which fails to
assemble a cumulus matrix and is infertile [62].
Oocyte pickup by the infundibulum is a complex process
that involves both ciliary beating and adhesion between
the oviductal epithelium and the oocyte cumulus com-
plex [63-73]. Both the inner and outer surfaces of the
infundibulum are covered with ciliated epithelium (Fig.
3) [74]. Following ovulation, the oocyte cumulus com-
plex travels along the outer surface of the infundibulum
and enters the oviduct through the ostium (Fig. 3)
[45,75]. The complex then rapidly moves to the ampulla
where fertilization occurs. Although infundibular smooth
muscle may contract during the pick-up process, it does
not appear to be necessary for pick-up, which still occurs
when muscle contraction is inhibited with isoproterenol
[76].
Huang et al., developed an in vitro method for measuring
oocyte pickup rate using hamster infundibula [71]. At
room temperature, oocyte pickup rate averaged 55.2 +
10.6 um/sec and was dependent on the viscosity of the
culture medium and temperature. Moreover, complexes
were observed to move along particular pathways on the
surface of the infundibula depending on where they were
placed. This in vitro bioassay has subsequently evolved to
allow measurement of smooth muscle contraction [77]
and adhesion of the oocyte cumulus complex to the
infundibulum [72].
Schematic diagram of an oocyte cumulus complex after ovulation from an ovarian follicle Figure 2
Schematic diagram of an oocyte cumulus complex after ovulation from an ovarian follicle. The oocyte and polar body are con-
tained within the zona pellucida. Immediately outside the zona, cells are densely packed to form the corona radiata outside of 
which are numerous cumulus cells. The cumulus cells are widely separated from each other by spaces filled with an extracellu-
lar matrix (matrix is shown in Figure 5).Reproductive Biology and Endocrinology 2005, 3:52 http://www.rbej.com/content/3/1/52
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The hamster infundibular explant has also been used to
analyze the process of pick-up in hamsters in conjunction
with video microscopy [45]. While small particles such as
Lycopodium spores can move over the infundibular surface
in the currents created by ciliary beating [45,78], the large
mass of the oocyte cumulus complex does not allow it to
move in the fluid currents created by ciliary beating alone.
In addition to ciliary beating, adhesion between the
cumulus cell matrix and the tips of the cilia is necessary to
move the complex over the surface of the infundibulum
[45,72]. The cumulus matrix attaches the complex to the
infundibulum, and as the cilia beat in the direction of the
ostium, the oocyte cumulus complex glides over the sur-
face of the infundibulum until it reaches and enters the
ostium. Figure 4 (Additional file 1) links to a video show-
ing the movement of a hamster oocyte cumulus complex
over the surface of an infundibulum. Additional videos of
this process can be viewed at http://www.talbotcen
tral.ucr.edu/oocytemovie.htm. In hamsters, the oocyte
cumulus complex is larger in diameter than the opening
of the ostium, and in order for the complex to enter the
oviduct, it goes through a "churning" process that com-
pacts the matrix between the cumulus cells making the
complex small enough to pass through the ostium [45].
During churning, the oocyte is sometimes squeezed from
the center of the complex to the periphery. Pick-up of a
human oocyte cumulus complex has been observed in
vivo  using transvaginal hydrolaparascopy and involves
adhesion of the complex to the tumescent fimbria of the
infundibulum with ciliary beating drawing the complex
into the ostium [75].
Adhesion plays an essential role in the pick-up process
(Fig. 5) [66,72]. Oocytes denuded of cumulus cells are not
picked up [66], and when matrix is not secreted by the
cumulus cells, the complex fails to attach to the
infundibulum and it is not moved into the oviduct [72].
Polycationic compounds can block oocyte cumulus
Scanning electron micrograph showing a hamster oocyte cumulus complex, colorized blue, entering the ostium of an  infundibulum Figure 3
Scanning electron micrograph showing a hamster oocyte cumulus complex, colorized blue, entering the ostium of an infundibu-
lum. The outer and inner surfaces of the infundibulum are covered with cilia (inset).Reproductive Biology and Endocrinology 2005, 3:52 http://www.rbej.com/content/3/1/52
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complex pick-up apparently by blocking transient adhe-
sion between the tips of the cilia and the complex [67].
Interestingly, peritoneal fluid from women with endome-
triosis contains a macromolecule (< 100,000 kDa) that
when assayed with hamster infundibula in vitro coats the
cilia on the surface of the infundibula and blocks adhe-
sion and hence pick-up of the human oocyte cumulus
complex by the hamster infundibulum [79,80]. Transmis-
sion electron microscopy revealed that adhesion during
complex pickup occurs specifically between the cumulus
matrix and the crowns at the tips of the infundibular cilia
[72]. An in vitro assay using vacuum from a low flow per-
istaltic pump has been developed to measure adhesion
between the oocyte cumulus complex and infundibulum
[72]. This assay was used to show that factors that either
increase or decrease adhesion can interfere with the pick-
up process. If the matrix of the oocyte cumulus complex is
made less sticky by compacting it or treating it with poly-
l-lysine, the complex cannot adhere tightly enough to the
infundibulum to be successfully picked up [72]. Con-
versely, if adhesion is increased, for example by treating
complexes or the oviduct with the lectin wheat germ
agglutinin, ciliary beating is not strong enough to tran-
siently detach the complex and move it to the ostium.
Thus successful pick-up requires a delicate balance
between proper strength of adhesion of the complex to
the infundibulum and ciliary beating towards the ostium.
The ampulla serves as a reservoir for the oocyte cumulus
complex, and hormonally controlled oviductal secretions
play an important role in creating a suitable microenvi-
ronment for fertilization and initial preimplantation
development [37,44,81,82]. After entering the female
reproductive tract, sperm are stored in a reservoir near the
uterotubal junction [42]. As some sperm leave the reser-
voir and move through the isthmus of the oviduct, they
become fully capacitated and their motility becomes
hyperactivated [38,83,84]. Hyperactivation is thought to
be critical to fertilization as it allows sperm to detach from
the oviductal epithelium, move in the lumen of the ovi-
duct, and penetrate through the extracellular matrices
surrounding the oocyte [84]. Sperm meet the oocyte
cumulus complex in the ampulla where fertilization nor-
mally occurs, and after fertilization, the preimplantation
embryo undergoes cleavage as it is transported through
the ampulla and the isthmus to the uterus for implanta-
tion [47]. Movement through the ampulla may involve
both ciliary beating and smooth muscle contraction.
When sections of the ampulla were surgically reversed in
their orientation, few rabbits became pregnant [85]. In
cases where pregnancy did occur, muscle contraction
apparently overcame ciliary beating toward the ovary,
showing that the cilia in the ampulla normally play an
important role in controlling movement into the isthmus
[85]. The isthmus of the oviduct is essential for normal
reproduction, as its removal results in infertility [86].
(2) Transport of preimplantation embryos to the uterus
A number of factors can influence the transport of preim-
plantation embryos through the ampulla and isthmus of
the oviduct. Interestingly, the oviduct can distinguish
between unfertilized oocytes and preimplantation
embryos. which are transported at different rates, with
embryos reaching the uterus one day earlier than unferti-
lized oocytes [87]. The production by embryos of platelet-
activating factor (PAF), which mediates signaling to the
oviduct, accelerates the passage of preimplantation
embryos, but not oocytes, through the oviduct [88]. PAF
may affect transport by increasing ciliary beating [89].
Human embryos likewise release PAF in vitro, and human
oviducts synthesize both the PAF receptor and PAF acetyl-
hydrolase, which degrades PAF, further supporting a role
for PAF in the embryo-oviductal dialogue [90]. When rat
embryos of different ages were transferred to the oviduct
of pregnant females, older embryos reached the uterus
before younger ones, again suggesting differential trans-
port rates of embryos that depend on age [91]. These data
from hamsters and rats support the idea that embryo
transport is at least, in part, subtly controlled by the
Micrograph showing a hamster oocyte cumulus complex,  stained blue, on the outer surface of an infundibulum Figure 4
Micrograph showing a hamster oocyte cumulus complex, 
stained blue, on the outer surface of an infundibulum. Click 
the link to view a video of this complex being picked up by 
the oviduct. Reprinted from Molec Biol Cell 10:5–9, 1999 
(with permission). See also http://www.rbej.com/imedia/
2132055580757722/sup1.movReproductive Biology and Endocrinology 2005, 3:52 http://www.rbej.com/content/3/1/52
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embryos themselves. Other factors such as maternal age
and parity also influence embryo transport [92]. In ham-
sters, transport to the uterus occurred faster in young nul-
liparous females than in nulliparous or multiparous adult
females. In the group of young females, but not the adults,
development of the embryos was also highly
synchronous.
Transport of preimplantation embryos through the ovi-
duct is accomplished by smooth muscle contraction and
ciliary beating [76,93]. However, the relative
contributions of these two processes are not yet
completely understood, and it is probable that both play
roles in transport. The ampulla and isthmus are both
lined by ciliated cells, which beat in the direction of the
uterus [76]. The relative number of cilia decreases and the
thickness of the muscle layers increases proceeding
toward the uterine end [94], suggesting that cilia become
relatively less important in the isthmus. Muscle contrac-
tion produces oscillating movements in the isthmus
[64,95,96] that result in a net transport of preimplanta-
tion embryos towards the uterus [97]. Nitric oxide syn-
thase inhibitors increased muscular activity in rats, and
this was accompanied by increased rate of movement of
eggs or microspheres in the oviduct [97]. These data sup-
port the idea that that muscle contraction can modulate
(speed or slow) transport through the oviduct. Muscle
contractions may also be important in keeping embryos
grouped together as they are transported through the isth-
mus [98].
Muscle contraction in the oviduct is regulated by a variety
of factors; however, the interplay of these factors with
each other is not yet well understood. The oviductal mus-
cles are innervated by the sympathetic nervous system
[99,100]. Stimulation of α adrenergic receptors promotes
contraction of the oviductal muscles, while stimulation of
β receptors inhibits contractions [100-102]. Alternating
contraction and relaxation produce the oscillatory
movements involved in embryo transport. However, the
adrenergic neurons may not be the primary means for
controlling embryo transport since experimental deple-
tion or inhibition these neurons does not prevent trans-
port nor decrease fertility [35]. Chemicals produced by
the oviduct itself or the preimplantation embryo can also
modulate muscle contraction and may play the lead role
Micrographs showing adhesion between the oocyte cumulus complex and the infundibulum Figure 5
Micrographs showing adhesion between the oocyte cumulus complex and the infundibulum. (A) Stereoscopic micrograph of an 
oocyte cumulus complex, colorized blue, being pulled off the surface of an infundibulum using forceps. The matrix of the com-
plex adheres to the infundibulum. Complexes do not adhere to most other surfaces. (B) Scanning electron micrograph of 
cumulus matrix adhering to cilia on the outer surface of an infundibulum. The matrix was left behind by an oocyte cumulus 
complex that was picked-up by the infundibulum.Reproductive Biology and Endocrinology 2005, 3:52 http://www.rbej.com/content/3/1/52
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in embryo transport. Oviductal muscle responds to sex
steroids and prostaglandins. Endogenous estrogens stim-
ulate oviductal muscle contraction, while progesterone
relaxes it [103]. Likewise the prostaglandins PGF and PGE
contract and relax oviductal muscle respectively [104-
106]. Human oviduct smooth muscle also produces the
prostaglandin prostacyclin which decreases muscle con-
tractility and may affect embryo transport [107]. Oviduc-
tal smooth muscle also contains a nitric oxide system
[108] that promotes muscle relaxation [109]. Inhibition
of nitric oxide syntheses in rats increases oviductal motil-
ity and results in accelerated movement of embryos
through the oviduct [97]. In additions to prostaglandins,
the oviduct produces, endothelin-1 [110] and angiotensin
II [111] which are involved in modulating oviductal mus-
cle contraction and regulation of embryo transport.
Recent data from the cow suggest that tumor necrosis fac-
torα from the oviductal epithelium, immune cells of the
oviduct, or even the embryo itself stimulates the release of
these effectors from the oviductal epithelial cells [111]. A
newly uncovered transport regulatory mechanism
involves the cannabinoid receptor CB1 [112]. When CB1
is genetically or pharmacologically silenced, embryos are
retained in the oviduct. This effect can be reversed by iso-
proterenol, a β adrenergic agonist. These data suggest that
cannabinoid signaling is important in coordinating ovi-
ductal muscle contraction, and is necessary for proper
embryo transport. While this review deals with conven-
tional cigarette exposure, these results with the CB1 recep-
tor suggest that exposure to marijuana for either
recreational use or pain relief could affect embryo trans-
port and hence female fertility. It is clear from the preced-
ing that the regulation of embryo transport through the
oviduct is complex and may depend on multiple regula-
tory mechanisms, some of which are just now being
identified.
(3) Biological importance of pick-up and transport by the 
oviduct
Timing of oocyte pick-up and embryo transport is critical
as the preimplantation embryos must arrive in the uterus
during the window when implantation can occur
[113,114]. If the oocyte is not picked up by the oviduct or
if the embryo moves through the oviduct too quickly or
too slowly, implantation may fail to occur or may be
ectopic. In rats, embryo transport was accelerated by treat-
ment with methoxychlor, an estrogenic pesticide, and the
embryos failed to implant in the uterus [115]. Likewise
women treated with ergonovine maleate, a powerful stim-
ulant of oviductal contraction, showed decreased concep-
tion rates when the drug was delivered immediately post
coitus [116]. Interference with embryo transport can
adversely affect fertility and in humans lead to ectopic
implantation.
C. Evidence that the oviduct is a target of 
cigarette smoke
While epidemiological studies have been clear in identify-
ing increased reproductive risks for women who smoke
both actively and passively (Section A), the reasons that
smoke causes reproductive problems are usually not
understood. Some of the risk factors for women smokers,
such as ectopic pregnancy, failure to conceive, increased
time to conception, could be due to effects of smoke on
the pick-up and transport by the oviduct. We will next
examine the in vivo and in vitro evidence supporting the
idea that the oviduct is targeted by cigarette smoke.
(1) In vivo evidence that the oviduct is a target of smoke
Direct inhalation of whole smoke has been shown in sev-
eral studies to adversely affect the oviduct. Oviductal
motility is altered in humans [117] and in rabbits [118]
by inhalation of mainstream smoke. Inhalation of main-
stream or sidestream smoke by hamsters, at serum coti-
nine levels that were within the ranges found in active and
passive human smokers (mainstream = 72.8 and
sidestream = 14.9 ng cotinine/mL) produced blebbing of
the oviductal epithelium at the ultrastructural level and
decreased the ratio of ciliated to secretory cells in the
ampulla [119]. In a related study on hamsters, inhalation
of either mainstream or sidestream smoke at levels that
produced serum cotinine levels equivalent to those in
human smokers (mainstream = 50–250 and sidestream =
18–80 ng cotinine/ml) slowed preimplantation embryo
transport through the oviduct [120]. In addition, muscle
contractions of the ampulla were significantly inhibited in
vivo during smoke exposure, supporting the conclusion
that embryo transport rates were slowed by inhibition of
smooth muscle contraction [120]. While smooth muscle
contraction rates did increase after smoke exposure
stopped, they did not return to control levels, showing
that inhibition of contraction by smoke is not immedi-
ately completely reversible.
Several in vivo studies using animal models have estab-
lished that the oviduct is a target of nicotine, a major con-
stituent of cigarette smoke. When administered to mice in
drinking water, nicotine (108 µmol/L) significantly
decreased Na and K ion concentrations in the oviductal
epithelium [121]. In addition, nicotine injected subcu-
tanenously (2.5 mg twice daily) into rats produced a sig-
nificant increase in lactate dehydrogenase levels in
flushings of the oviduct in early pregnancy [122]. While a
change in the ionic composition of the oviductal epithe-
lium or its secretions might adversely affect adhesion of
the oocyte to the oviductal surface and the oocyte pick-up
process, the relationship between these nicotine-induced
changes and oviductal functioning has not yet been estab-
lished experimentally. Nevertheless, these studies doReproductive Biology and Endocrinology 2005, 3:52 http://www.rbej.com/content/3/1/52
Page 8 of 17
(page number not for citation purposes)
demonstrate that nicotine exerts effects on the oviductal
epithelium.
Two additional studies on rats indicate further effects of
nicotine on oviductal functioning. When pregnant rats
were treated with pharmacological doses of nicotine (2.5
mg injected subcutaneously twice daily), preimplantation
embryo transport was inhibited [123]. In addition, nico-
tine (5 mg/kg), when injected subcutaneously twice daily
in pregnant rats, both retarded embryonic development
and reduced blood flow to the oviduct [124]. Reduction
of oviductal blood flow decreases smooth muscle contrac-
tion, which in turn can delay embryo transport [124,125].
In other studies, nicotine slowed oviductal contraction in
vivo in the Rhesus monkey, which may prevent implanta-
tion [126]. Oral nicotine administration through drinking
water (108 µmol/L) also interfered with oocyte matura-
tion, fertilization, and early pregnancy in mice [121]. Col-
lectively these data show that nicotine affects the
composition and secretions of the oviductal epithelium,
adversely affects preimplantation development, retards
movement of embryos through the oviduct, and reduces
blood flow to this organ.
In a study involving gamete intrafallopian transfer (GIFT),
no differences were found among active, passive and non-
smokers in number of oocytes retrieved; however the
number of live births after GIFT was significantly lower for
active smokers (10.5%) than for passive smokers (23.1%)
or non-smokers (33.3%) smokers [127], which could
indicate an effect of smoke on the human oviduct.
Taken together these in vivo studies demonstrate that the
oviduct responds to exposure to both whole mainstream
and sidestream smoke and to nicotine and that the trans-
port of preimplantation embryos can be inhibited by cig-
arette smoking, apparently by an inhibition of oviductal
smooth muscle contraction. In vivo studies have not yet
been undertaken to determine if oocyte cumulus complex
pick-up is slowed in smoke exposed animal models or
humans.
(2) In vitro evidence that smoke affects oviductal 
functioning
In vitro models have facilitated studies on smoke's effect
on the oviduct and have further supported the conclusion
that the oviduct is responsive to chemicals in cigarette
smoke (Fig. 6, additional file 2). A hamster infundibular
explant model [71] has been used to simultaneously
measure ciliary beat frequency, adhesion, oocyte pick-up
rate, and muscle contraction, before, during, and after
exposure to smoke or its constituents [70,128-133]. In
general, in vitro studies show that mainstream and side-
stream smoke solutions adversely affect proper function-
ing of the oviduct. Mainstream and sidestream smoke
solutions made from University of Kentucky 2R1 research
cigarettes in a medium lacking bovine serum albumin
(BSA) inhibited ciliary beat frequency in a dose depend-
ent manner [128]. When BSA was included in the
medium, mainstream solutions continued to inhibit beat
frequency, while sidestream solutions either had no effect
or slightly stimulated beat frequency, suggesting that the
presence of BSA influenced how sidestream smoke
affected beat frequency [129]. Interestingly, in both main-
stream and sidestream solutions containing BSA, oocyte
pickup rate was inhibited in a dose-dependent manner
with sidestream smoke often being more inhibitory than
mainstream smoke (Fig. 6). Since ciliary beat frequency
was either not affected or slightly stimulated in sidestream
smoke, these data show that smoke can inhibit oocyte
pick-up rate by affecting factor(s) other than ciliary beat
frequency. Oocyte pickup rate was more sensitive to the
gas than the particulate phase of mainstream and side-
stream smoke solutions [129].
Since pick-up rate decreased in sidestream smoke when
beat frequency increased, oocyte pick-up rate must
depend on factor(s) other than ciliary beat frequency
[129]. Since adhesion of the oocyte cumulus complex to
the tips of the cilia is important in oocyte pick-up
[66,68,72], the effect of smoke solutions on adhesion was
measured in vitro using the hamster infundibular model.
Both mainstream and sidestream solutions inhibited
oocyte cumulus complex pick-up rate and increased
adhesion of the cumulus to the oviduct [133]. As was
shown previously using wheat germ agglutinin [72],
increasing adhesion by exposure to smoke leads to a
decrease in pick-up rate since the complex can not be
moved by the cilia if it adheres too tightly to the oviduct.
These effects on adhesion and pick-up rate were observed
when only the oocyte cumulus complex was pretreated
with smoke solution or when only the infundibulum was
pretreated, indicating that both the cumulus matrix and
oviduct are targets of smoke treatment [133]. The oviduct
was more sensitive to treatment than the oocyte cumulus
complex, perhaps because smoke pretreatment affected
both ciliary beat frequency and adhesion of infundibula
but only adhesion of oocyte cumulus complexes. These
data indicate that factors that increase adhesion of the
oocyte cumulus complex to the cilia can decrease pick-up
rate and explain why both mainstream and sidestream
smoke solutions decrease pick-up rate even when ciliary
beat frequency is increased by treatment with sidestream
smoke.
The above studies were all done using non-filtered 2R1
research brand cigarettes manufactured at the University
of Kentucky. A subsequent study examined the effects on
oviductal functioning of smoke solutions from a filtered
research brand cigarette (1R4F), various traditionalReproductive Biology and Endocrinology 2005, 3:52 http://www.rbej.com/content/3/1/52
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filtered and non-filtered commercial cigarettes (Marlboro
Red, Marlboro Light, Camel filtered, Camel unfiltered,
Kool, and Kool with the filter removed), and three brands
of harm reduction cigarettes (Advance, Omni and Omni
Light) [134]. Harm reduction cigarettes have recently
been introduced commercially and are claimed to contain
fewer carcinogens than traditional commercial brands
[135]. All of the cigarettes tested (research, traditional
commercial, harm reduction) adversely affected oviductal
functioning, and the effects were in general stronger on
oocyte pick-up rate and smooth muscle contraction than
on ciliary beating. Sidestream smoke generally produced
a stronger effect in all assays than mainstream smoke solu-
tion. Smoke from the 1R4F cigarettes, which more closely
resemble the commercial brands smoked today than the
2R1 cigarettes, was considerably more inhibitory in the
pick-up rate and muscle contraction assays than the 2R1s.
Except for mainstream smoke from Marlboro Lights and
Kools, all traditional brand smoke solutions reduced pick-
up rate by more than 60%. Except for mainstream smoke
from Marlboro Lights and Camel filtered, all smoke solu-
tions from traditional brands reduced muscle contraction
by more than 80%. Smoke from harm reduction cigarettes
reduced pick-up rate by 50–80% and reduced muscle con-
traction by 30–98% depending on the type of smoke and
brand. These data show that the adverse effects observed
on oviducts with 2R1 research cigarettes are also produced
by filtered research cigarettes and by filtered, non-filtered
and light commercial brands. Moreover, harm reduction
cigarettes, while reduced in levels of carcinogens, still con-
tain toxicants that can impair oviductal functioning.
Pick-up rate could also be altered by action of smoke on
the oocyte cumulus complex, in particular the matrix
which is required for adhesion to the cilia [72]. Both
mainstream and sidestream smoke solutions from 2R1
cigarettes caused more dispersal of hamster cumulus cells
during in vitro incubation than control medium lacking
smoke, and oocyte pick-up rate was slowed when oocyte
cumulus complexes were pretreated with smoke prior to
measuring pick-up rate [133]. In addition,in vitro expo-
sure of porcine oocyte cumulus complexes to nicotine,
cadmium, and anabasine, all components of cigarette
smoke, suppressed FSH induced expansion of the cumu-
lus and decreased synthesis and accumulation of
hyaluronic acid in the cumulus matrix [136]. These stud-
ies show that the matrix of the oocyte cumulus complex is
also a target of cigarette smoke and damage to the matrix
can affect pick-up of complexes by the oviduct.
D. What chemicals in cigarette smoke impair 
oviductal functioning?
(1) Chemicals most studied in smoke
Cigarette smoke is a complex suspension that contains
over 4,000 chemicals distributed between a gaseous and
particulate phase [17]. Most studies on cigarette smoke
and its components have focused on nicotine [137-139],
carcinogens [140,141], polycyclic aromatic hydrocarbons
(PAHs) [142-144], such as benzo-a-pyrene, tobacco-spe-
Micrographs showing oocyte cumulus complex pick-up by a hamster infundibulum of a control (6B) and a sidestream smoke  treated (6A) preparation Figure 6
Micrographs showing oocyte cumulus complex pick-up by a hamster infundibulum of a control (6B) and a sidestream smoke 
treated (6A) preparation. Click the link to view a video of this experiment. During approximately 10 seconds of observation, 
the control complex moves toward the ostium while the smoked treated complex does not move. Reprinted from Molec Biol 
Cell 10:5–9, 1999 (with permission). See also http://www.rbej.com/imedia/1622614392757722/sup2.movReproductive Biology and Endocrinology 2005, 3:52 http://www.rbej.com/content/3/1/52
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Table 1: Chemicals in Cigarette Smoke that Impair Oviductal Functioning 1
LOAELs (M)2
CHEMICALS Oocyte Ciliary Beat Contraction FEMA FDA ADDED5
Pick-up Rate Frequency Rate GRAS3 EAFUS4
PYRIDINES
2-ethylpyridine 9.35 × 10-12 9.35 × 10-12 9.35 × 10-12
4-methylpyridine 9.50 × 10-11 9.50 × 10-11 9.50 × 10-11
2-methylpyridine 9.35 × 10-11 9.35 × 10-11 9.35 × 10-10
4-ethenylpyridine 9.30 × 10-11 9.30 × 10-9 9.30 × 10-11
3-ethylpyridine 9.33 × 10-10 9.33 × 10-11 9.33 × 10-10 √√√
Nornicotine 6.85 × 10-9 6.85 × 10-8 6.85 × 10-8
beta-nicotyrine 6.33 × 10-9 6.30 × 10-8 X6
2,4,6-trimethylpyridine 8.25 × 10-8 8.25 × 10-6 8.25 × 10-8
2,4-dimethylpyridine 9.34 × 10-7 X6 9.34 × 10-9
2,3-dimethylpyridine 9.34 × 10-7 9.34 × 10-7 X6
4,4-bipyridine 8.78 × 10-6 8.78 × 10-7 8.78 × 10-4
2,5-dimethylpyridine 9.34 × 10-5 X6 9.34 × 10-5
3,4-dimethylpyridine 1.76 × 10-5 X6 1.76 × 10-4
pyridine 1.27 × 10-5 1.27 × 10-3 1.27 × 10-3 √√√
3-methylpyridine 1.23 × 10-5 Xd 1.23 × 10-2
2,2-bipyridine 8.74 × 10-4 8.74 × 10-2 8.74 × 10-2
cotinine 2.84 × 10-2 2.84 × 10-5 X6
nicotine 9.01 × 10-2 X6 6.70 × 10-2
PYRAZINES
2-methoxy-3-methylpyrazine 10-12 10-9 10-12
pyrazine 10-11 10-12 10-9 √√
2-methylpyrazine 10-11 10-12 10-11 √√√
2-ethylpyrazine 10-11 10-12 10-12 √
2,5-dimethylpyrazine 10-11 10-8 10-9 √√√
2,3,5-trimethylpyrazine 10-10 10-9 10-9 √√√
2,6-dimethylpyrazine 10-9 10-6 10-7 √√√
PHENOLS, INDOLES, OTHERS
Indole 10-14 10-13 10-15 √
Isoquinoline 10-13 10-12 10-13 √
4-Ethylphenol 10-12 10-11 10-12 √√
Quinoline 10-11 10-13 10-11 √
4-Methylphenol 10-11 10-12 10-11 √√
2-Methylphenol 10-11 10-9 10-11 √√
5-Methylindole 10-11 10-10 10-10
2,6-Dimethoxyphenol 10-11 10-10 10-9 √
Hydroquinone 10-10 10-10 10-10
3-Methyl-2-cylcopenten-1-one 10-10 10-7 10-10
2,4-Dimethylphenol 10-10 10-9 10-9
2-Methoxyphenol 10-10 10-8 10-8
2-Cyclopenten-1-one 10-9 10-7 10-9
4-Methoxyphenol 10-8 10-7 10-7
2-Ethylphenol 10-8 10-5 10-7
2,5-Dimethylphenol 10-7 10-8 10-6
Benzene 10-7 10-8 10-6
Phenol 10-2 10-1 10-2 √
1Compiled from References 131, 132, and 135.
2LOAEL = Lowest observed adverse effect level in the oocyte pick-up rate, ciliary beat frequency, and muscle contractions assays.
3Chemicals known to be on the FEMA GRAS list. Others may also be on this list.
4Chemicals on the FDA EAFUS list (Everything Added to Food in the United States).
5Chemicals that are added to cigarettes by American tobacco companies.
6No effect at the highest dose tested.Reproductive Biology and Endocrinology 2005, 3:52 http://www.rbej.com/content/3/1/52
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cific nitrosamines [145,146], carbon monoxide
[147,148], tar [149-151], metals (cadmium, lead)
[152,153], and ten to fifteen other compounds including,
phenol, acrolein, acetaldehyde, hydrogen cyanide, and
formaldehyde [17,154-164]. Most of these chemicals
have been linked to cancer or cardiovascular and lung dis-
ease. Of the 4,000 compounds found in cigarette smoke,
at least 50 are known carcinogens [141]. PAHs and
tobacco-specific N-nitrosamines are major contributors to
lung cancer [154,161,165,166], while tar and carbon
monoxide are major contributors to cardiovascular dis-
ease and chronic obstructive lung diseases [161,163,167].
PAHs have also been shown to initiate or promote athero-
sclerosis in avian [168-170] and mammalian [171] mod-
els. The PAH benzo(a)pyrene, induces atherosclerosis by
stimulating proliferation of vascular smooth muscle cells
that migrate into the vessel lumen [172,173].
(2) Chemicals in smoke that affect the oviduct
Most of the above-mentioned chemicals that are com-
monly studied in smoke have not been studied with
respect to their effects on the oviduct. An exception is nic-
otine, which did alter oviductal epithelium secretion and
ion composition, embryo transport, embryo develop-
ment, and oviductal blood flow in several in vivo studies
(Section C1) and cumulus expansion in vitro [136].
(a) Ciliotoxic chemicals
Numerous studies have shown that cigarette smoke con-
tains chemicals that are toxic to cilia of the mammalian
respiratory system [174-178], the amphibian palate [179],
Paramecium [180,181], and the gills of mussels, clams,
and mollusks [182,183]. Moreover, nicotine increased cil-
iary beat frequency in the ferret trachea [184], formalde-
hyde inhibited respiratory cilia in the rabbit and pig
[185]; and hydrogen cyanide, acrolein, and acetaldehyde
inhibited ciliary beating in the clam [182]. Using an in
vitro infundibular bioassay, the individual smoke constit-
uents, which had been previously shown to be ciliotoxic
in non-oviductal systems [175,176,182], were tested spe-
cifically for their effect on oviductal cilia [186]. Potassium
cyanide (KCN), acrolein, phenol, acetaldehyde, and for-
maldehyde all inhibited ciliary beat frequency in a dose
dependent manner in vitro [186]. However, only KCN was
present in cigarette smoke solutions in a high enough con-
centration to account for the effect seen in vitro. KCN also
inhibited oocyte pick-up rate. Nicotine did not inhibit cil-
iary beat frequency of the hamster oviduct, except at
extremely high doses (Talbot, unpublished data).
(b) Pyridines, pyrazines, and phenols
Since cigarette smoke contains over 4000 compounds
[17], there are likely other chemicals present in main-
stream and sidestream cigarette smoke that can adversely
affect oviductal functioning. To identify such chemicals,
mainstream smoke solution from 2R1 cigarettes was
fractionated by passage through 12 different solid phase
extraction cartridges [77]. The eluates from each cartridge
were screened using the hamster infundibular bioassay,
and three cartridges were identified that retained inhibi-
tory activity in the ciliary beat frequency, oocyte pick-up
rate, and smooth muscle contraction bioassays. The
chemicals in the eluates of each cartridge were then iden-
tified using GC-MS, and authentic standards of the identi-
fied compounds were purchased from commercial
sources and tested independently to determine their activ-
ity in each of the three infundibular bioassays.
Pyridines, pyrazines, and phenols were the three major
groups of chemicals identified in the inhibitory eluates
(Table 1) [77,131,132]. Several other types of compounds
including quinolines, indoles, and cyclopenten-1-ones
were also present [132]. Within all groups, chemicals were
identified that were highly inhibitory in all three bio-
assays, and some of the chemicals had LOAELs (lowest
observed adverse effect levels) in the nano, pico and
femtomolar range (Table 1). In general, if a chemical were
inhibitory, it acted in all three bioassays, although the
potency and efficacy for a particular chemical varied
among the assays. Some of the compounds that were
identified in this screen (Table 1) were previously thought
to be safe and are included on the FEMA GRAS list (Flavor
and Extract Manufacturers' Association – Generally
Regarded As Safe) and the FDA EAFUS list (Everything
Added to Food in the United States). Some of these
chemicals are added to tobacco to flavor it (Table 1). For
example, 3-ethylpyridine, which was inhibitory in all
three bioassays at picomolar doses, is on the list of 599
chemicals added to tobacco in the United States [187]. Of
the seven pyrazines tested, six are on the FDA EAFUS list,
and in all but three assays, the pyrazines had LOAELs in
the nanomolar or picomolar range. Indole and isoquino-
line were the most toxic of all chemicals tested with
LOAELs in the femtomolar range, except for isoquinoline
which had a picomolar LOAEL in the ciliary beat fre-
quency assay.
Many of the compounds in Table 1 were also screened
using a chick chorioallantoic membrane (CAM) assay that
measures growth of the CAM and chick embryo
[188,189]. In the CAM assay, many pyridines and pyra-
zines inhibited CAM growth dramatically, even at very
low doses, and in some cases they also inhibited embryo
growth. It is interesting that the chemicals in Table 1 were
inhibitory in assays that measure diverse biological proc-
esses (ciliary beat frequency, oocyte pick-up, smooth
muscle contraction, growth). It is not yet known if inhibi-
tion occurs by distinct mechanisms or if a basic underly-
ing mechanism, such as inhibition of ATP production,
was affected. Nor is it known if the chemicals act directlyReproductive Biology and Endocrinology 2005, 3:52 http://www.rbej.com/content/3/1/52
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or indirectly, but given the extremely low effective doses
of some of the chemicals, activation of a signaling cascade
is possible.
These data from the oviduct and CAM studies indicate a
need for further toxicological testing on the chemicals in
Table 1, especially since some of them are used routinely
in consumer products including food, cigarettes and cos-
metics. These data also indicate a need for additional stud-
ies on the chemicals in smoke in general. The solid phase
cartridge screen found about 40 oviductal toxicants, most
of which were not previously recognized as smoke toxi-
cants. It is probable that there are other toxicants in ciga-
rette smoke that have not yet been identified as harmful
nor studied in detail.
E. Concentrations of smoke toxicants in 
cigarettes and in human smokers
The data on oviductal toxicants beg the question – what
are the concentrations of these compounds in cigarette
smoke and in actual active and passive smokers? Some of
the oviductal toxicants, such as nicotine, have been stud-
ied extensively, and concentrations are well documented
in both cigarettes and smokers [17,190-192]. The LOAEL
concentrations of 2-ethylpyridine, 2-methylpyridine, and
3-ethylpyridine are about 10,000 to a million times lower
than the concentration of these chemicals in mainstream
and sidestream smoke from commercial cigarettes and
cigars [77,193]. However, some of these toxicants, such as
3-ethylpyridine, have not previously been recognized as
harmful, and little is known about their concentrations, in
smokers. Many chemicals were inhibitory in the infundib-
ular bioassays at nano and picomolar doses suggesting
that they could be effective in vivo at extremely low doses
that would be difficult to detect and measure.
Concentrations of cigarette smoke components, such as
phenolic compounds, vary among different brands of cig-
arettes [194]. For example, different types of cigarettes,
such as Indian Bidi cigarettes, have higher concentrations
of phenols than traditional commercial cigarettes [157].
Concentrations of chemicals also vary between various
research brand cigarettes [195]. Finally, the source of the
smoke also affects chemical concentration. While main-
stream and sidestream smoke have similar chemicals the
relative amounts of particular chemicals can vary signifi-
cantly between the two types of smoke [17].
Cigarette smoke chemicals or their metabolites must gain
access to the circulatory system and reach their target
organs to exert their toxicity. Studies have measured nico-
tine, cotinine (a metabolite of nicotine), and other ciga-
rette smoke components in reproductive tissues, although
little is known about concentrations in the oviduct per se.
Interestingly, levels of cigarette toxicants in reproductive
tissues or fluids can be significantly higher than in serum.
For example, pregnant rabbits injected with tritiated nico-
tine had 5–11 times higher nicotine concentrations in
uterine fluid than in plasma [196]. Both nicotine [197]
and phenols [198] have been detected in the cervical fluid
of smokers, and nicotine concentrations in the cervical
fluid (66–2620 ng/ml) were significantly higher than in
serum (0.1–39 ng/ml) [199].
Cigarette smoke components have also been detected in
the follicular fluid of smokers [200,201]. Cotinine, a
biomarker for smoke exposure, was higher in the follicu-
lar fluid of active smokers (mean = 285.69 ng/ml; range =
62.21–595.00) than passive smokers (mean = 29.65 ng/
ml; range = 20.91–45.75) and nonsmokers (mean = 3.71
ng/ml; range = 1.20–15.62) [200]. Cadmium, like other
smoke components, does reach and accumulate in the
follicular fluid of smokers (7.93 ng/mL) [202], and cad-
mium concentration in the ovary was elevated in smokers
(150 ng/g) versus nonsmokers (115 ng/g) [203]. While
cadmium apparently does not interfere with embryo
transport through the oviduct in the rat [204], it is another
example of a smoke toxicant that can accumulate in repro-
ductive organs and which, in laboratory animals, can
adversely affect reproduction [205]. While many of the
toxicants that affect the oviduct have not been quantified
in smokers and there is little known about their concen-
trations in the oviduct, those chemicals that have been
studied, appear to reach the reproductive organs and are
often found in higher concentration in reproductive tis-
sues and fluids than in serum or urine.
F. Summary
The oviduct, while seemingly a simple organ, is exqui-
sitely designed to convey gametes in opposite directions
virtually simultaneously and to provide a suitable envi-
ronment for preimplantation development and transport
of embryos to the uterus for implantation. It is vital for
reproductive success. Factors that interfere with its func-
tioning can adversely affect fertility. The oviduct serves as
a useful model to evaluate the effect of cigarette smoke
and its components on a reproductive organ and in a
more general sense on a variety of biological functions.
While most work on smoke's effect on the oviduct has
been done on ciliary beat frequency, oocyte pick-up rate,
cilia-oocyte cumulus complex adhesion, and smooth
muscle contraction, other parameters of oviductal func-
tioning could be added to this array of bioassays. For
example, monitoring the synthesis and secretion of the
oviductal proteins may give further insight into how
smoke affects oviductal functioning and secretory proc-
esses in general. The oviductal assays have been useful in
identifying numerous smoke toxicants many of which
were not previously recognized as harmful and some of
which are widely used in consumer products. Further
studies on the safety of these chemicals are needed. Com-Reproductive Biology and Endocrinology 2005, 3:52 http://www.rbej.com/content/3/1/52
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mercial brands of cigarettes contain toxicants capable of
shutting down oviductal functions in vitro and interest-
ingly sidestream smoke is often more inhibitory than
mainstream smoke. Harm reduction cigarettes, while
apparently reduced in carcinogens, still contain chemicals
that impair basic biological processes including ciliary
beating, oocyte pick-up, and smooth muscle contraction.
The effects of smoke on the heart and lungs is widely
known and well documented. The effects of smoke on the
oviduct, which are just recently becoming more widely
recognized, demonstrate that organs remote from the site
of inhalation may be adversely affected by chemicals in
smoke are consistent with the idea that all organs are tar-
gets of smoke [1]. Active and passive smokers of reproduc-
tive age should be made aware of the possible dangers in
smoking and how smoking could affect their reproductive
ability.
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